2025 NOSCM | Prostate Cancer: Early and Locally Advanced Disease

2025 NOSCM | Prostate Cancer: Early and Locally Advanced Disease

Overview

Dr. Ulka Vaishampayan discussed early and locally advanced prostate cancer, noting 192,000 new U.S. cases yearly. Key biomarkers include PSA, imaging, and genomics. High-risk cases may need surgery, radiation, or hormone therapy. Tools like Decipher and Artera AI aid decisions. Multidisciplinary care is key.

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Ulka Vaishampayan, MD

Date of Release

July 20th, 2025